John W. Dorbin Jr. - 23 Oct 2023 Form 4 Insider Report for DMK PHARMACEUTICALS Corp

Role
General Counsel
Signature
/s/ John W. Dorbin, Jr.
Issuer symbol
N/A
Transactions as of
23 Oct 2023
Net transactions value
$0
Form type
4
Filing time
02 Nov 2023, 16:50:52 UTC
Previous filing
01 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DMK Employee Stock Option (right to buy) Award $0 +70,000 $0.000000 70,000 23 Oct 2023 Common Stock 70,000 $0.5800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 1/8 of the total number of shares subject to the option on the six-month anniversary of the grant date and thereafter monthly with respect to 1/48 of the total number of shares subject to the option.